Market Place
Sourcing Support
Tallac Therapeutics Presents TAC-001 Preclinical Data at AACR
10 Apr 2024 //
BUSINESSWIRE
Tallac Presents First Clinical Data for TAC-001 at SITC 2023
03 Nov 2023 //
BUSINESSWIRE
Tallac Therapeutics Announces Two Abstracts Accepted for Presentation
27 Sep 2023 //
BUSINESSWIRE
Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer
19 Jan 2023 //
BUSINESSWIRE
Tallac Presents Data for Two, First-in-Class Toll-like Receptor 9 Agonist
12 Nov 2022 //
BUSINESSWIRE
Tallac Therapeutics Announces First Patient Dosed with TAC-001
28 Jul 2022 //
BUSINESSWIRE
Tallac Therapeutics Announces FDA Clearance of IND Application for TAC-001
19 May 2022 //
BUSINESSWIRE
Selexis and Tallac Therapeutics Collaborate to Advance Tallac’s Pipeline
23 Mar 2021 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.